Adhesion and Safety of Rotigexole Compared to Neupro®

NCT07015346 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Parkinson Disease

Interventions

DRUG: Rotigexole 8 mg
DRUG: Neupro ® 8 mg

Sponsor

Eva Pharma

Collaborators

[object Object]